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Abstract
Background: Some, though not all studies have reported an increased risk for mental health problems after an
induced abortion. Problems with design and data have compromised these studies and the generalisation of their
results.
Methods: The Finnish Medication and Pregnancy database (N = 622 671 births and 114 518 induced abortions for
other than fetal reasons) in 1996-2006 was utilised to study the use of psychotropic drugs in the three months
before a pregnancy ending in a birth or an induced abortion.
Results: In total 2.1% of women with a birth and 5.1% of women with an induced abortion had used a
psychotropic medicine 0-3 months before pregnancy. Psychotropic drug users terminated their pregnancies
(30.9%) more often than other pregnant women (15.5%). Adjustment for background characteristics explained one
third of this elevated risk, but the risk remained significantly increased among users of psychotropic medicine (OR
1.94, 95% confidence intervals 1.87-2.02). A similar risk was found for first pregnancies (30.1% vs. 18.9%; adjusted OR
1.53, 95% confidence intervals 1.42-1.65). The rate for terminating pregnancy was the highest for women using
hypnotics and sedatives (35.6% for all pregnancies and 29.1% for first pregnancies), followed by antipsychotics
(33.9% and 36.0%) and antidepressants (32.0% and 32.1%).
Conclusions: The observed increased risk for induced abortion among women with psychotropic medication
highlighs the importance to acknowledge the mental health needs of women seeking an induced abortion.
Further studies are needed to establish the impact of pre-existing differences in mental health on mental health
outcomes of induced abortions compared to outcomes of pregnancies ending in a birth.
Background
The connection of induced abortion and subsequent
mental health problems is controversial. Studies from
countries with free or relatively liberal abortion legisla-
tion have suggested that women experiencing an
induced abortion have a higher risk for depression [1-5],
anxiety [2,5-10], suicide [11,12], suicidal behaviour [2],
substance use disorders [2], and any mental health pro-
blem requiring outpatient treatment [13] after the pro-
cedure. In most of these studies, the available
confounding factors did not explain the elevated risk for
harmful outcomes.
Some other studies, however, have reported no ele-
vated risk for any psychiatric disorder [14], anxiety
[7,15] or depression [1,5,16,17] among women who had
experienced induced abortion. In Israel, pregnancy ter-
mination has been shown to result in a significant
reduction in the pre-abortion psychological distress level
[18]. A Swedish study reported no suffering or any sub-
sequent regret or negative effects one year after termina-
tion [19]. Studying welfare more broadly, a study from
New Zealand reported that young women who became
pregnant before age 21 and terminated their pregnancy
had even better outcomes on education, income, welfare
dependence and domestic violence compared to young
women who did not seek an abortion [20]. A recent
review [21] concluded that in 21 eligible studies on the
connection of induced abortion and long-term mental
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mixed findings.
Two reviews have concluded that studies on post-
abortion mental health problems often face significant
problems related to their design or data [21,22]. Termi-
nated pregnancies are usually compared with pregnan-
cies ending in a birth, but it would be essential to
disaggrate them by pregnancy intention and to analyse
intended and unintended (i.e. unwanted and mistimed)
pregnancies separately. Information on pregnancy inten-
tion prior to pregnancy is, however, seldom available.
Retrospective collection of such data may be biased, and
the data remains unavailable in routinely collected
databases.
Another major problem is that the mental health mea-
surement is not always based on validated diagnostic
instruments [21], which can be collected either prospec-
tively or retrospectively from medical records and by
using surveys. In register studies, the mental health
measurements have been based on physician’s diagnosis
on inpatient or outpatient care [13] or, in case of sui-
cide, on main cause of death [11,12].
The third major problem is how confounders are con-
trolled. In several studies, the number of background
variables describing common determinants of mental
health has been limited, and important determinants
have remained unavailable. Information on pre-existing
mental health status has seldom been available, even
though it has been shown to be an important explana-
tory factor for the increased risk for negative mental
health outcomes in several [7,14], though not in all stu-
dies [16]. Since induced abortion and mental health pro-
blems share same risk factors - such as young age [12],
poor socioeconomic circumstances, violence [3,7], and
rape history [7] - the causality between induced abortion
and subsequent mental health problems cannot be
straightforwardly concluded without taking into consid-
eration their common determinants.
Our aim was to clarify the pre-existing mental health
status among pregnant women by using the Medication
and Pregnancy database with information on all births
and induced abortions in Finland in 1996-2006. We
u s e dt h ep u r c h a s eo fp s y c h o t r o p i cd r u g si nt h et h r e e
months before pregnancy as a proxy measure of mental
health status and calculated the risk for terminated
pregnancy among women purchasing such drugs com-
pared to other women with no purchases. First pregnan-
cies were separately analysed to avoid bias caused by
previous pregnancies. Selective terminations of preg-
nancy due to fetal anomalies were excluded, since these
are originally wanted pregnancies, unlike pregnancies
ending in an induced abortion in general.
Methods
The nationwide Finnish Medication and Pregnancy data-
base was utilised in this study. The data on births were
based on the Medical Birth Register (MBR) and data on
induced abortion on the Register on Induced Abortions
and Sterilisations. Both of these registers are maintained
by the National Institute for Health and Welfare (THL).
1) MBR. All live births and stillbirths of fetuses with a
gestational age of 22 weeks or more or with a birth
weight of 500 grams or more have been included in the
register since 1987. The register data are collected from
all delivery hospitals and sent to THL. The register
includes the mother’s and the child’s personal identifica-
tion numbers, maternal obstetrical and social back-
ground, health care and interventions during pregnancy
and delivery, as well as the newborn’s outcome until the
age of seven days. Data quality studies have shown that
the majority of the register content corresponded well
or satisfactorily with hospital record data [23].
2) Register on Induced Abortions. This register col-
lects data on all induced abortions performed in Finland
since 1977 [24]. National legislation requires permission
and an indication for terminating a pregnancy. An
induced abortion can be perfomed for social reasons
(age less than 17 years or 40 years or more at concep-
tion, delivered four children or more, or social circum-
stances), medical reasons (health of the pregnant
woman, suspected or confirmed congenital anomaly or
birth defect, or mother’sa n d / o rf a t h e r ’s incapability to
take care of the child) or ethical reasons (rape or incest).
The legislation on induced abortions is interpreted liber-
ally, and 97% of the pregnancy terminations during the
study period were performed on social reasons. If the
permission for an induced abortion is not granted, a
national board will assess the case and grant the permis-
sion unless the gestational age limit of 20 weeks
(24 weeks in case of confirmed congenital anomaly or
birth defect) has not been passed.
Once the pregnancy has been terminated, a notifica-
tion is sent to THL within one month of the procedure.
The register includes women’s personal identification
number, information on women’s background, the pro-
cedure, and complications occurring at the hospital.
According to a 1993 data quality study, more than 99%
of induced abortions mentioned in hospital records
were reported to the register, and for most variables,
agreement between the register data and the hospital
record was good [24].
By using woman’s personal identification number,
pregnancy data was linked to information on all reim-
bursed psychotropic drugs, defined as Anatomic Thera-
peutic Classification (ATC) categories N05 and N06
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of pregnancy.
3) The information on drugs was retrieved from the
Register on Reimbursement Drugs, established in 1994
by the Social Insurance Institution. It includes informa-
tion on the purchases of drugs that have been reim-
bursed under the health insurance scheme, which covers
virtually all drug prescriptions for all residents of Fin-
land. The register does not include information on OTC
medicines, nor medicines used in hospitals and a few
non-reimbursable drugs. The information is collected
from all pharmacies, and the register includes informa-
tion on purchaser, drug, dispensing and prescribing phy-
sician. Information on the purchased drug includes the
Nordic Commodity Number (trade name, pharmaceuti-
cal form, strength, pack size, number of DDDs per pack-
age, marketing authorisation holder, and ATC code),
number of packs received, price, reimbursement, and
date of prescribing [25].
The Finnish Medication and Pregnancy database for
1996-2006 included information on 622 671 pregnancies
ending in a birth and 117 229 induced abortions. We
separately analysed 243 788 first pregnancies (197 120
births and 46 668 induced abortions) to avoid any bias
caused by previous pregnancies and their end-point
(birth, induced abortion or spontaneous abortion).
Induced abortions due to fetal reasons were excluded
(N = 2711 and 704, respectively).
We calculated the number of terminated pregnancies
per one hundred ended pregnancies (ending in a birth
or an induced abortion) for total pregnancies and by the
following maternal characteristics:
- year of birth or induced abortion (from 1996 to
2006)
- age at birth or induced abortion (less than 20,
20-24, 25-29, 30-34, 35-39, 40 years or more)
- region (21 central hospital districts)
- marital status (married, cohabiting, single,
unknown)
- previous pregnancies (0, 1, 2, 3 or more, unknown)
- previous births (0, 1, 2, 3 or more, unknown)
- previous induced abortions (0, 1 or more,
unknown) and
- socioeconomic position based on woman’s occupa-
tion (upper-white collar worker, lower-white collar
worker, blue-collar worker, student, unknown).
The following ATC categories were analysed:
- N05 or N06: any tranquilising, antidepressant or
psychostimulant drug
- N05A: antipsychotics
- N05B: anxiolytics
- N05C: hypnotics and sedatives
- N06A: antidepressants
- N06B: psychostimulants and nootropics and
- N06C: psycholeptics and psychoanaleptics in
combination.
Results for the ATC group N06B are not shown in
the Tables due to the low rate of prescription and
the small number of pregnancies (N = 28). The odds
ratios (OR) for a pregnancy ending in an induced
abortion were calculated with 95% confidence inter-
vals (CI). The ORs were futher adjusted using
logistic regressions by the following background
variables: year, age, region, marital status and socio-
economic position.
Ethical approval: the National Institute for Health and
Welfare (THL), and the Social Insurance Institution
(KELA) have given their permission to use their health
data for the Pregnancy and Medicine -project. The
board of the Pregnancy and Medicine project approved
this study. Since the final database is anonymous, no
informed consent of the registered person or a state-
ment from the research ethical board was required.
Results
In total, 15.5 out of 100 pregnancies were terminated
(Table 1). More than half of women aged less than 20
years and a quarter of women aged 40 years or more
terminated their pregnancies. Single women terminated
their pregnancies more than seven times more often
than those who were married and more than four times
more often than cohabiting, unmarried women. The
connection between previous obstetrical history and ter-
mination was U-shaped, andt h er i s kf o rt e r m i n a t i o n
was the lowest for second pregnancies and births. If the
women had at least one previous induced abortion, the
risk for termination more than doubled (31% vs. 13%).
Students terminated one out of three pregnancies (34%),
while the risk was significantly lower for blue-collar
workers (14%), lower-white collar workers (9%) and
upper-white collar workers (5%).
The likelihood to terminate a first pregnancy was
higher, 18.9 per 100 first pregnancies (Table 1). The
maternal background risk factors were similar for all
pregnancies. Compared with their subsequent pregnan-
cies, young women aged less than 20 years (the relative
risk being 25% higher), single women (+15%) and stu-
dents (+54%) had a higher risk to terminate their first
pregnancies. Similarly, the risk to terminate their first
pregnancy was significantly decreased for women aged
30 years or more (the relative risk was 11% lower), for
married or cohabiting women (-15%) and for upper and
lower white-collar workers (-9%) compared to their sub-
sequent pregnancies.
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with an induced abortion had used a psychotropic medi-
cine 0-3 months before pregnancy. The percentages
doubled in both groups, from 1.5% to 2.9% among women
with a birth and from 3.9% to 7.4% among all women with
induced abortion during the study period of 11 years.
By background characteristics, the use of psychotropic
medicine before a pregnancy ending with a birth was
increased for women aged less than 20 years and aged
35 years or more, single women, women having three or
more births, women having at least one induced abor-
tion and for blue-collar workers (Table 2). For women
terminating their birth, the use of psychotropic medicine
increased by age and it was also increased for single
women, multiparous women, and women with repeated
induced abortion. Differences by socioeconomic position
were relatively small.
Among women having used psychotropic medica-
tion before pregnancy, 30.9 out of 100 pregnancies
were terminated, giving a 2.5-fold risk compared to
women not using such medication (Table 3). Preg-
nancy termination and use of psychotropic medicine
shared common risk factors, and the adjustment for
background variables explained slightly more than
one third of the excess risk. Even after the back-
ground standardisation, however, the risk for women
h a v i n gu s e dap s y c h o t r o p i cm e d i c i n eb e f o r ep r e g -
nancy to end in a pregnancy termination was signifi-
cantly increased (adjusted OR = 1.94, 95% confidence
interval 1.87-2.02).
By type of medication, the highest risk for terminating
pregnancy was observed for women using hypnotics
and sedatives (35.6%, adjusted OR = 2.25, 95% CI 2.02-
2.49), antipsychotics (33.9%, adjusted OR = 1.85, 95% CI
Table 1 Background characteristics of pregnancies ending in births and induced abortions in Finland 1996-2006
All pregnancies First pregnancies
Births Induced abortions Induced abortions, % Births Induced abortions Induced abortions, %
N 622 671 114 518 15.5 197 120 45 964 18.9
Age
Less than 20 17 517 24 798 58.5 13 202 21 016 61.3
20-24 103 343 27 997 21.3 51 647 14 801 22.2
25-29 199 249 21 532 9.7 73 937 6 073 7.6
30-34 188 793 18 989 9.1 42 969 2 574 5.6
35-39 92 810 14 646 13.5 13 235 1 120 7.7
40 or more 20 959 6 556 23.5 2 130 380 14.8
Marital status
Married 376 705 23 931 5.9 95 184 1 373 1.4
Cohabiting 150 070 18 779 11.1 62 148 5 530 8.1
Single 85 033 71 805 45.7 35 675 39 061 52.2
Previous births
0 257 119 58 791 18.6 - - -
1 206 033 20 385 9.0 - - -
2 97 137 21 717 18.2 - - -
3 or more 61 023 13 625 18.2 - - -
Previous induced abortions
0 542 605 79 404 12.7 - - -
1 or more 78 214 35 092 30.8 - - -
Socioeconomic position
Upper-white collar w. 108 957 6 270 5.4 37 597 1 632 4.1
Lower-white collar w. 236 149 23 341 9.0 69 481 5 446 7.3
Blue-collar worker 95 751 15 464 13.9 27 529 4 026 12.7
Student 55 481 28 442 33.8 28 769 20 908 42.0
Other 126 333 41 001 24.4 33 744 13 952 29.1
Excluding 2711 and 704 induced abortions due to fetal reasons.
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ATC code N05/N06 N05A N05B N05C N06A N06C
Births Induced
abortions
Births Induced
abortions
Births Induced
abortions
Births Induced
abortions
Births Induced
abortions
Births Induced
abortions
Users 13 327 5 951 1 233 633 3 381 1 601 1 413 780 9 940 4 667 379 110
Per 100
women
2.1 5.1 0.2 0.5 0.5 1.4 0.2 0.7 1.6 4.0 0.1 0.1
Age
Less than 20 2.3 2.5 0.3 0.2 0.4 0.3 0.1 0.1 1.9 2.2 0.1 2.2
20-24 2.0 4.5 0.2 0.4 0.5 0.2 0.1 0.4 1.6 1.9 0.0 1.9
25-29 1.8 5.7 0.2 0.6 0.4 0.3 0.2 0.6 1.4 2.5 0.0 2.5
30-34 2.0 6.5 0.2 0.7 0.6 0.3 0.2 1.1 1.5 2.8 0.1 2.8
35-39 2.7 7.0 0.3 0.8 0.8 0.4 0.4 1.2 1.9 3.6 0.1 3.6
40 or more 3.9 6.4 0.5 0.6 1.0 0.9 0.8 1.4 2.6 7.8 0.2 7.8
Marital status
Married 1.8 4.4 0.2 0.2 0.5 1.3 0.2 0.4 1.3 2.1 0.1 2.1
Cohabiting 2.3 4.5 0.2 0.2 0.5 1.2 0.2 0.5 1.8 2.8 0.0 2.8
Single 3.3 5.5 0.3 0.1 1.0 1.4 0.4 0.1 2.5 0.8 0.1 0.8
Previous pregnancies
0 2.1 3.7 0.2 0.1 0.5 2.2 0.2 0.2 1.6 1.2 0.1 1.2
1 or more 2.2 6.0 0.2 0.1 0.6 1.5 0.2 0.1 1.6 0.8 0.1 0.8
Previous births
0 2.2 4.4 0.2 0.1 0.5 1.7 0.2 0.2 1.7 0.9 0.1 0.9
1 1.8 6.2 0.2 0.2 0.5 4.9 0.2 0.5 1.3 2.5 0.1 2.5
2 2.3 5.7 0.2 0.2 0.6 4.7 0.2 0.4 1.7 2.5 0.1 2.5
3 or more 2.7 5.3 0.3 0.3 0.7 7.5 0.3 0.7 2.0 3.9 0.1 3.9
Previous induced abortions
0 1.9 4.2 0.2 0.4 0.5 1.3 0.2 0.1 1.5 0.7 0.1 0.7
1 or more 3.5 7.1 0.4 1.0 1.1 2.9 0.5 0.3 2.6 1.5 0.1 1.5
Socioeconomic position
Upper-white
collar w.
1.7 4.8 0.1 5.1 0.3 15.5 0.3 1.5 1.2 8.1 0.1 8.1
Lower-white
collar w.
1.9 5.1 0.2 1.4 0.5 4.3 0.2 0.4 1.4 2.3 0.1 2.3
Blue-collar
worker
2.3 4.8 0.2 2.2 0.7 6.6 0.2 0.6 1.6 3.5 0.1 3.5
Other 2.6 5.2 0.3 0.5 0.6 1.5 0.2 0.1 2.0 0.8 0.1 0.8
Excluding 2711 induced abortions due to fetal reasons.
N05/N06 Any in ATC categories N05 and N06
N05A Antipsychotics
N05B Anxiolytics
N05C Hypnotics and sedatives
N06A Antidepressants
N06B Psychostimulants and nootropics
N06C Psycholeptics and psychoanaleptics in combination
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2.00, 95% CI 1.92-2.09).
For first pregnancies, the share of terminated pregnan-
cies (30.1 per 100) among women using psychotropics
and their risk (adjusted OR 1.53, 95% CI 1.42-1.65) were
slightly smaller than for all pregnancies (Table 4). By
type of medication, the highest risk for terminating
pregnancy was found for women using antipsychotics
(36.0%, adjusted OR = 1.73, 95% CI 1.39-2.16), antide-
pressants (32.1%, adjusted OR = 1.57, 95% CI 1.44-1.71),
and hypnotics and sedatives (29.1%, adjusted OR = 1.74,
95% CI 1.36-2.22).
Table 3 The proportion of terminated pregnancies among women using psychotropic medicine 0-3 months before
pregnancy, Finland 1996-2006
ATC code N05/N06 N05A N05B N05C N06A N06C
Terminated pregnancies per 100 30.9 33.9 32.1 35.6 32.0 22.5
Age
Less than 20 60.3 53.6 47.0 64.2 62.0 35.3
20-24 37.6 41.7 11.8 46.0 24.2 19.6
25-29 26.0 31.8 6.8 29.8 16.2 13.5
30-34 25.0 30.0 5.7 34.1 16.4 17.5
35-39 29.5 31.7 8.1 33.0 23.6 30.9
40 or more 35.5 28.9 22.3 38.0 50.3 32.1
Marital status
Married 13.9 6.2 15.9 12.0 9.8 11.7
Cohabiting 20.5 12.3 22.7 22.1 16.9 18.4
Single 58.5 12.4 56.2 22.7 20.7 55.0
Previous pregnancies
0 30.1 9.5 53.6 20.2 14.9 17.9
1 or more 31.2 4.7 29.6 8.8 7.4 24.3
Previous births
0 31.4 6.6 43.2 13.7 11.1 0.0
1 26.4 11.3 52.7 21.1 16.5 0.0
2 36.2 19.7 62.7 29.8 25.1 28.7
3 or more 31.2 20.4 69.8 33.9 31.2 31.4
Previous induced abortions
0 24.6 26.7 29.4 8.7 6.4 12.2
1 or more 47.7 55.0 54.6 20.4 21.3 0.0
Socioeconomic position
Upper-white collar worker 15.1 76.1 74.3 25.3 29.4 8.4
Lower-white collar worker 21.4 47.2 46.3 17.8 14.0 25.3
Blue-collar worker 25.6 62.1 61.0 29.3 25.9 23.9
Other 43.2 39.4 47.5 18.4 12.7 26.3
Crude OR 2.51 2.80 2.60 3.02 2.62 1.58
95% CI 2.43-2.59 2.55-3.08 2.45-2.76 2.76-3.29 2.53-2.71 1.28-1.96
Adjusted OR1) 1.94 1.85 2.02 2.25 2.00 1.69
95% CI 1.87-2.02 1.65-2.08 1.88-2.16 2.02-2.49 1.92-2.09 1.32-2.17
Explanation, % 37 53 36 38 38 < 0
Excluding 2711 induced abortions due to fetal reasons.
1) Adjusted by year, age, region, marital status, socioeconomic position and gravidity.
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Our data included information on more than 737 000
pregnancies and several background variables. The
data were derived from compulsory nationwide, popu-
lation-based registers with high completeness and
quality [23,24]. It did not, however, cover all pregnan-
cies, since register information on pregnancies ending
in spontaneous abortions before 22 weeks of gestation
was not included in our database. In general, such data
remain unavailable, if treated in primary health care in
Finland.
We used information on purchases on psychotropic
medication as a proxy of mental health disorders. Psy-
chotropic medication is the dominating treatment
approach in Finland. For instance 80% of those with an
anxiety disorder using health care services for mental
health reasons receive pharmacotherapy [26]. People
with more severe mental health problems are more
prone to seek health care [27] and thus receive
prescriptions. Our proxy measure of mental ill health
thus covers the majority of severe cases, but most likely
will not identify all mild cases of mental ill health. A
further step in the analysis would be to combine the
information on purchases of psychotropic medication
with hospital inpatient and outpatient data. Gathering
this data both before and after pregnancy would allow
analyses on the relationship between mental disorders
and pregnancy in more detail.
The information on medication is more or less com-
plete as psychotropics are not sold over the counter in
Finland and practically all psychotropics are reimbursa-
ble, and thus included in our data. However, we lack
information on the use of psychotropic medicine from
previous prescriptions or other people’s medication. We
even lack information on medication given in hospital
care, even though its share has diminished along the
rapid deinstitutionalising of mental health services.
Finally, because our data on medication were based on
Table 4 The proportion of terminated pregnancies among primigravidas using psychotropic medicine 0-3 months
before pregnancy, Finland 1996-2006
ATC code N05/N06 N05A N05B N05C N06A N06C
Terminated pregnancies per 100 30.1 36.0 25.7 29.1 32.1 17.9
Age
Less than 20 62.4 56.0 47.5 64.9 64.0 30.0
20-24 36.5 44.8 32.1 43.5 38.1 26.9
25-29 20.8 29.5 22.6 24.6 21.3 9.3
30-34 15.9 25.9 15.7 14.5 16.9 6.3
35-39 19.8 28.6 22.0 22.1 20.6 27.8
40 or more 22.5 4.3 20.0 27.9 23.6 60.0
Marital status
Married 3.6 6.5 3.9 4.1 3.6 0.0
Cohabiting 14.8 21.3 13.6 14.8 14.8 11.8
Single 58.0 59.1 51.4 55.2 60.4 52.6
Socioeconomic position
Upper-white collar worker 9.3 10.8 5.4 5.6 10.9 3.1
Lower-white collar worker 16.6 21.5 14.6 22.7 16.6 18.0
Blue-collar worker 19.7 25.0 17.9 18.0 21.8 6.7
Other 44.5 46.3 41.0 45.3 45.9 35.1
Crude OR 1.88 2.42 1.49 1.76 2.07 0.94
95% CI 1.78-2.00 2.05-2.86 1.31-1.69 1.47-2.12 1.94-2.20 0.60-1.46
Adjusted OR
1) 1.53 1.73 1.46 1.74 1.57 1.40
95% CI 1.42-1.65 1.39-2.16 1.25-1.75 1.36-2.22 1.44-1.71 0.79-2.53
Explanation, % 40 49 1 4 47 < 0
Excluding 704 induced abortions due to fetal reasons.
1) Adjusted by year, age, region, marital status and socioeconomic position.
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whether the medication was actually ingested or not.
We were partly able to overcome the main methodo-
logical problems, which commonly complicate studies
on the connection of mental health problems and
induced abortion. We excluded induced abortions due
to fetal reasons from our analysis. In these cases, these
pregnancies are most often wanted, while most other
induced abortions relate to unplanned or mistimed
pregnancies. We did not have information on pregnancy
intention on women whose pregnancy ended in a birth.
Data from large Finnish birth cohort studies have shown
that the proportion of unwanted pregnancies has
decreased from 12.2% in 1966, before the current legis-
lation on induced abortions, to 1.0% in 1985-1986 [28].
Thus, we can assume that only a small proportion of
births are unwanted in contemporary Finland.
Second, we used register information on psychotropic
medication prescribed by physicians. Such prescriptions
are based on a medical diagnosis. We do, however, miss
the women who have not seeked (mental) health care
services, as well as women with mild mental disorders
not requiring medication. Their proportions remain
unknown in our study population, but the more severe
mental disorder is, the less likely is it that the woman
would have been misclassified.
Third, our register data included several important
confounders, which were utilised in estimating the effect
of women’s age, previous pregnancy history, marital sta-
tus, socio-economic status and region of residence on
the risk of induced abortion. Other confounding factors
can only be gathered by other means: by collecting med-
ical records, by interviewing or by using postal question-
naires. Since this would not be feasible with such a large
study material as we had, it remains unknown how
much the unmeasured confounding explains our
findings.
The Finnish Medication and Pregnancy database also
included data on medication three months after the
pregnancy. We did not use this data to evaluate mental
disorders post-abortion, because of the use of tranquilis-
ing, antidepressant or psychostimulant drugs decreases
significantly after birth due to labelling of these drugs as
unsafe during lactation. According to the current
national standards, 72 of the 180 psychotropic medicines
in ATC classes N05 and N06 (40%) are labelled as pos-
sibly harmful and 50 (28%) clearly harmful during
breastfeeding. Thus, all comparisons between births and
induced abortions would have been biased. A longer fol-
low-up period is needed to study the connection of pre-
existing psychotropic medication and the long-term
effects of pregnancy and its end on mental health. Since
our data showed that women with induced abortion dif-
fer substantially from women in general, the collection
of even more detailed background information would be
recommended. This includes for example data on pre-
existing confirmed diagnosis related to mental health,
education, annual income, employment status, and
social assistance, which are all available in the Finnish
register system [29].
The use of psychotropic medication among young
women has increased in Finland since the mid-1990s. In
the general Finnish population, the number of people
with at least one reimbursement for tranquilising drugs
(N05) increased by 8% and that of antidepressant and
psychostimulant drugs (N06) by 24% between 2000 and
2005 [30]. This trend - caused by the improved avail-
ability of new types of psychotropic medication with
fewer side effects, increased identification of mental dis-
orders and changes in help-seeking patterns - was con-
firmed by our data consisting of women in reproductive
age.
Our nationwide data provide evidence that mental
problems are more common among women who subse-
quently have an induced abortion, even before preg-
nancy. Thus, any finding of an increased post-abortion
rate of mental disorders has to be contrasted against the
pre-existing rate, if conclusions of the impact of induced
abortion on womens mental health are to be made.
Most previous studies have failed to acknowledge the
high pre-existing rate, leading to biased conclusions
about the impact of induced abortion on mental health.
Furthermore, we show that the excess use of psycho-
tropic drugs among women who subsequently have an
induced abortion cannot be explained solely by common
background factors, such as marital status or socio-
economic position. Mental health problems severe
enough to lead to the use of psychotropics are an inde-
pedent risk factor for induced abortion. The aim to
reduce the number of induced abortions is a generally
accepted target for reproductive health in Finland [31].
Our results suggest that it would be important to iden-
tify actions how to promote the mental and reproduc-
tive health, especially among young women, single
women and women with previous induced abortions.
The current Finnish clinical practice guideline for
induced abortion does state that a post-abortion check-
up visit is necessary a few weeks after the procedure to
detect signs of depression and to identify the rare cases
of psychosis after an induced abortion [31]. Our findings
indicate that pre-existing mental disorders are more
common among women who have induced abortion,
and it adds justification to the current recommendation.
Abiding by this recommendation may improve women’s
health and diminish negative health consequences post-
abortion.
Finland has a lower abortion rate (9/1000 women aged
15-49 years in 2008) than the other Nordic countries on
Gissler et al. BMC Public Health 2010, 10:383
http://www.biomedcentral.com/1471-2458/10/383
Page 8 of 10average (14/1000 in 2007) or United States (16/1000 in
2005) [32]. Even if the impact of induced abortion on
mental health remains undetermined, the aim of
decreasing the number of induced abortions remains
important. The experience from Finland suggests that
this can best be done by advancing knowledge of sexual
and reproductive health and improving services related
to them.
The Finnish action plan on sexual and reproductive
health [33] states that sexual education should reach all
children and adolescents from preschool to secondary
education. Local, regional and national collaboration
between different professional groups and areas should
create common, cross-supportive aims for sexual educa-
tion and sexual health services. These services have to
be located near the clients, and if possible, as a separate
youth service. The selection of contraceptives should
cover all existing methods .T h ef u t u r ea i ms h o u l db e
that all medical examinations related to starting contra-
ception and monitoring its use should be free-of-charge.
Also a free-of-charge provision for contraceptives for
young people aged under 20 has been suggested. Our
results indicate that women with mental disorders and
mental health problems should be especially targeted to
further reduce the number of induced abortions.
Furthermore, our results indicate that the potential
impact of induced abortion on women’sm e n t a lh e a l t h
cannot be judged by comparing mental health of
women with a birth to women with an induced abortion
without taken into account the pre-existing mental
health and vulnerability of women who choose to termi-
nate their pregnancy.
Conclusions
Our data show that women who had used tranquilising,
antidepressant or psychostimulant medication prior to
their pregnancy terminate their pregnancies more often
than women without such medication. Our observations
should be utilised when improving care in general prac-
tice, gynaecology and mental health services. Similar,
though slightly lower risk was observed for women with
no previous pregnancies. This finding suggests that the
pre-existing mental health status is an essential factor,
which should be taken into account in trying to explain
the excess of mental disorders after an induced
abortion.
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